Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Evidence: MAGIC-derived ComparatorOnlyEvidence: Genital infection in GLP-1 RA Group in Adults with type 2 diabetes

Generated Narrative: Evidence 236979

version: 63; Last updated: 2024-12-14 08:46:28+0000

Profile: ComparatorOnlyEvidence

url: https://fevir.net/resources/Evidence/236979

identifier: FEvIR Object Identifier/https://fevir.net/FOI/236979, outcomeId/313964, picoId/85798, sectionId/73215

name: Genital_infection_Comparator_Evidence_from_MAGICapp_313964

title: MAGIC-derived ComparatorOnlyEvidence: Genital infection in GLP-1 RA Group in Adults with type 2 diabetes

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

author: Computable Publishing®: MAGIC-to-FEvIR Converter:

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationComparatorOnlyEvidence

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

RelatedArtifacts

-TypeResourceReference
*Part OfMAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

description:

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

variableDefinition

description:

Adults with type 2 diabetes -- GLP-1 RA

variableRole: Population

observed: GLP-1 RA Group in Adults with type 2 diabetes

variableDefinition

description:

Genital infection

variableRole: Outcome

observed: Genital infection

synthesisType: NOTSET

studyDesign: PRIMARY_STUDY

Statistics

-DescriptionStatisticTypeQuantity
*

Risk 5.0%

Proportion0.05